Premature Birth Drug Has No Benefit, But Serious Side Effect

Premature Birth Drug Has No Benefit, But Serious Side Effect

A drug that is used by pregnant women to prevent preterm birth may not only not be effective, but may increase the risk of a serious side effect, gestational diabetes.

The drug, Makena, is a synthetic progesterone known as 17-alpha hydroxyprogesterone caproate. It was approved by the FDA in 2011 to treat women at risk of delivering a second premature baby. The drug received accelerated approval in large part to a 2003 study published in the new England Journal of Medicine.

Makena is also endorsed American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine. However, the drug has been plagued by controversy due to its relatively high price tag and questions surrounding the 2003 study.

In the new study, researchers offered the drug to women if they had a history of premature births and were carrying a single fetus. The study followed a total of 430 women who took the drug at a Texas hospital. Those results were compared with the premature birth rate of 5,787 women at the same hospital who had a history of premature delivery but didn’t take the drug.

Premature birth occurred in 25% of the women that took Makena, compared to a 16.8% in women who never took the drug, researchers reported in the American Journal of Obstetrics and Gynecology. And the rate of gestational diabetes was 13.4% in women treated with Makena, compared with 8% in the historical group.

While gestational diabetes often goes away after birth, it can lead to the delivery of larger babies and higher chances for cesarean sections and other birth complications.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement